Streetbeat News

Partnerships

RCEL

AVITA Medical has entered into an exclusive distribution agreement with Stedical Scientific for the PermeaDerm Biosynthetic Wound Matrix in the United States. This agreement could potentially enhance AVITA's market presence in the US wound care market by providing a new product offering.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 9:04 pm

NCBDY

Brian Cox, known for his role in Succession, has partnered with Bandai Namco Holdings ADR (OTC:NCBDY) to narrate a five-minute recap of the Tekken series for newcomers, ahead of the release of 'Tekken 8'. The humorous recap simplifies the game's complex narrative, focusing on the theme of characters throwing each other off cliffs. The promotional video has been well-received, with fans enjoying the connection between Tekken's themes and Cox's portrayal of Logan Roy in Succession. Celebrity involvement in video game promotions is highlighted, with 'Tekken 8' set to release on January 26.

Portfolio Pulse from Franca Quarneti

January 10, 2024 | 8:53 pm

BYDDY

HMC

HYMTF

NSANY

TSLA

In Q4 2023, BYD Company Limited (OTC:BYDDY) outsold Tesla Inc (NASDAQ:TSLA) in EV sales for the first time, although Tesla met its annual goal with 1.8 million deliveries. Hyundai Motor Group (OTC:HYMTF) surpassed GM (NYSE:GM) and Ford (NYSE:F) in U.S. EV sales, with Hyundai and Kia gaining 7.5% of the U.S. market. Honda Motor Co Ltd (NYSE:HMC) and Nissan Motor Group Co Ltd (OTC:NSANY) also reported increased sales. Honda is considering a new EV plant in Canada and has partnered with GM for affordable EVs. Nissan is expanding its global EV presence and focusing on R&D with Tsinghua University.

Portfolio Pulse from Upwallstreet

January 10, 2024 | 8:52 pm

MGNI

Tennis Australia has chosen Magnite, a leading provider of programmatic advertising, to manage its advertising efforts. They have implemented Magnite's Demand Manager to streamline and optimize their ad placements.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 8:03 pm

CANSF

GTBIF

TCNNF

VFF

Willow Biosciences Inc. (OTCQB:CANSF) reported a 60% revenue increase in 2023, driven by its synthetic biology techniques and the launch of its BioOxi bio-oxidation platform technology. The company engaged in multiple partnerships, including with Kalsec and an undisclosed Nasdaq-listed biopharmaceutical company, and underwent corporate restructuring. For 2024, Willow Biosciences aims to achieve over 100% increase in R&D revenues, sign commercial agreements, and advance its core technology platform. The article also mentions cannabis stocks, including Green Thumb Industries Inc. (OTCQX:GTBIF), Trulieve Cannabis Corp. (OTCQX:TCNNF), and Village Farms International, Inc. (NASDAQ:VFF), as having potential for growth.

Portfolio Pulse from Jelena Martinovic

January 10, 2024 | 7:38 pm

BIIB

DNA

NVO

Ginkgo Bioworks Holdings Inc (NYSE:DNA) reported preliminary FY23 sales of $250-$260 million, aligning with consensus estimates. The company expects cell engineering and biosecurity revenue to be within guidance ranges and anticipates adding 80-85 new Cell Programs in 2023. William Blair views Ginkgo's update positively, despite a reduced full-year program target. Ginkgo completed collaborations with Novo Nordisk (NYSE:NVO) and Biogen Inc (NASDAQ:BIIB), and its cell engineering revenue from biopharma clients grew over 50% in 2023. The company ended the year with $950 million in cash and equivalents. However, concerns about growth feasibility and financial robustness persist, leading William Blair to maintain a Market Perform rating. DNA shares dropped 5.30% to $1.43.

Portfolio Pulse from Vandana Singh

January 10, 2024 | 7:29 pm

SONY

Sony Group Corporation (NYSE:SONY) shares rose after announcing a strategic venture with Roast Productions and success with the film 'Anyone But You'. Sony Music Masterworks will collaborate with Roast Productions on new live productions. The film 'Anyone But You' has grossed $60 million globally and may exceed $100 million. Sony's 'No Hard Feelings' earned $87 million globally. Additionally, Zee Entertainment's merger with Sony's Indian arm remains on track, countering rumors of its collapse. SONY shares increased by 4.29% to $96.06.

Portfolio Pulse from Nabaparna Bhattacharya

January 10, 2024 | 6:49 pm

EVO

Evotec SE (NASDAQ:EVO) has partnered with the Crohn's & Colitis Foundation to advance drug discovery for inflammatory bowel disease (IBD). The collaboration aims to develop novel therapies targeting fibrosis and compromised intestinal barrier function in Crohn's disease and ulcerative colitis patients. Financial terms were not disclosed. Despite the positive news, EVO shares have dropped by 2.53% to $9.530.

Portfolio Pulse from Nabaparna Bhattacharya

January 10, 2024 | 6:21 pm

Bloom Energy Corp (NYSE:BE) has entered into a sales agreement with SK Ecoplant for its electrolyzer technology, which is expected to generate significant revenues over the next 20 years. Baird analyst Ben Kallo upgraded Bloom Energy's rating to Outperform and raised the price target from $16 to $22, citing catalysts such as cost reductions, manufacturing improvements, and electrolyzer sales for 2024. Shares of Bloom Energy rose by 1.13% to $13.47 following the announcement.

Portfolio Pulse from Priya Nigam

January 10, 2024 | 6:20 pm

ARKK

Cathie Wood, on Bloomberg TV, discussed the unique nature of her ETF, mentioning ongoing talks with pension funds and treasurers. She tempered expectations by noting that success wouldn't be immediate as these institutions begin their due diligence processes.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 6:20 pm